R.PR
REGISTERED-PRINCIPAL REGISTER
03/04/2025
Back to search
Official data from USPTO
THE GENE LAY INSTITUTE OF IMMUNOLOGY AND INFLAMMATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE GENE LAY INSTITUTE OF IMMUNOLOGY AND INFLAMMATION
ST13
US500000098148447Class
36, 41, 42
Filing
98148447
Registration
7716888
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
03/04/2025
Trademark type
Word
Nice classes
36, 41, 42
Filing date
08/24/2023
Registration date
03/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2025
Last transaction
03/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/26/2023
First use in commerce
2024-08-00
Drawing code
4
Owner type
03
Owner location
Boston, MA, US
Examiner
WELLS, KELLEY L
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
The Brigham and Women's Hospital, Inc.
Representatives
Aaron Y. Silverstein SAUNDERS & SILVERSTEIN LLP
Technical classification
Nice Classes
Class 36Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Charitable fundraising services
Class 41
Providing courses of instruction in the field of health care; Providing continuing medical education courses; Medical training and teaching; Training services in the field of health care; Educational servicesconducting programs in the field of health carewellness and nutrition; Arranging and conducting educational conferences in the field of health care; Providing non-downloadable online videos featuring information on health care
Class 42
Medical research; Scientific research and development; Research and development in the fields of immunologyinflammationagingcancerpharmaceuticalsvaccinesmedicinesbiotechnology; Medical and scientific researchconducting clinical trials for others
Publications
History of USPTO decisions and trademark events.
22 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/04/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/13/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/13/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/13/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/12/2025
IUAF
USE AMENDMENT FILED
12/02/2024
EISU
TEAS STATEMENT OF USE RECEIVED
12/02/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2024
PUBO
PUBLISHED FOR OPPOSITION
04/16/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/20/2023
GNRT
NON-FINAL ACTION E-MAILED
12/20/2023
CNRT
NON-FINAL ACTION WRITTEN
12/20/2023
DOCK
ASSIGNED TO EXAMINER
12/19/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/24/2023
NWAP
NEW APPLICATION ENTERED
08/28/2023
Continuous trademark protection
Get notified about every new filing that threatens THE GENE LAY INSTITUTE OF IMMUNOLOGY AND INFLAMMATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.